Deprescribing Archives - Wiser Healthcare

Exploring Different Contexts of Statin Deprescribing: A Vignette-Based Experiment with Older Adults Across Four Countries – Kristie Rebecca Weir et al.

Lucia Marcello2024-04-07T16:33:55+10:00Ageing, Deprescribing, Polypharmacy, Primary Care, Publications, Risk|

Deprescribing is the process of a healthcare professional reducing or stopping an inappropriate medication. Statins, commonly prescribed to prevent cardiovascular events, pose uncertain benefits and potential harms for older adults, making deprescribing a preference-sensitive decision. Deprescribing studies typically ask general questions about deprescribing preferences; however, [...]

Association of state-level prescription drug monitoring program implementation with opioid prescribing transitions in primary care in Australia – Ting Xia et al.

Lucia Marcello2024-04-07T14:41:17+10:00Clinical guidelines, Deprescribing, Opioids, Pain, Prescribing, Primary Care, Publications, Risk|

This study aimed to evaluate whether voluntary and mandatory prescription drug monitoring program (PDMP) use in Victoria, Australia, had an impact on prescribing behaviour, focusing on individual patients' prescribed opioid doses and transition to prescribing of nonmonitored medications.

Supporting conversations about medicines and deprescribing: GPs’ perspectives on a Medicines Conversation Guide – Kristie Rebecca Weir et. al

Lucia Marcello2023-01-18T14:17:06+11:00Ageing, Deprescribing, Publications, Shared decision making|

Deprescribing can be an appropriate intervention when a person’s medications shift towards an unfavourable benefit-to-harm ratio due to changes in an older adult’s medications, health conditions, preferences and treatment goals. To elicit an individual’s preferences and to understand their goals of care, it is essential [...]

Effectiveness of Opioid Analgesic Medicines Prescribed in or at Discharge From Emergency Departments for Musculoskeletal Pain – Caitlin M.P. Jones et. al

Lucia Marcello2023-01-11T12:13:10+11:00Deprescribing, Opioids, Publications|

The risk–benefit balance of opioids versus placebo, paracetamol, NSAIDs, and local or systemic anesthetics is uncertain. Opioids may have equivalent pain outcomes compared with NSAIDs, but evidence on comparisons of harms is very uncertain and heterogeneous. Although factors such as route of administration or dosage [...]

The slow de-implementation of non-evidence-based treatments in low back pain hospital care-Trends in treatments using Dutch hospital register data from 1991 to 2018 – Pieter Coenen et al

Thomas Dakin2023-01-11T16:18:24+11:00Back pain, Deprescribing, Low back pain, Musculoskeletal, Publications|

In the Netherlands, de-implementation of five non-recommended hospital LBP treatments, if at all, took several decades. Although de-implementation was substantial, slow de-implementation has likely resulted in considerable waste of resources and avoidable harm to many patients in Dutch hospitals.

Barriers and enablers to monitoring and deprescribing opioid analgesics for chronic non-cancer pain: a systematic review with qualitative evidence synthesis using the Theoretical Domains Framework – Amanda Cross et al.

Thomas Dakin2022-03-10T15:33:31+11:00Deprescribing, Opioids, Pain, Publications|

Understanding barriers and enablers to monitoring and deprescribing opioids will enable the development of tailored interventions to improve both practices. To perform a qualitative evidence synthesis of the barriers and enablers to monitoring ongoing appropriateness and deprescribing of opioids for chronic non-cancer pain (CNCP) and [...]

Deprescribing Opioids in Chronic Non-cancer Pain: Systematic Review of Randomised Trials

Thomas Dakin2021-05-28T11:07:38+10:00Deprescribing, Opioids, Pain, Publications|

Deprescribing is the process of reducing or discontinuing unnecessary or harmful medicines. To address the ‘opioid epidemic’, clinical practice guidelines now discourage the initial prescription of opioid analgesics for chronic non-cancer pain and strategies such as the introduction of Prescription Drug Monitoring Programs may reduce [...]

Rethinking “long term” opioid therapy – Christina Abdel Shaheed, Andrew McLachlan, Christopher Maher

Thomas Dakin2020-01-23T16:02:20+11:00Definition complexity, Deprescribing, Publications|

Long term opioid therapy for non-cancer pain has been much debated because of concerns that the harms may outweigh benefits. What has received less attention is how long term should be defined and whether the label has any value for patients, doctors, or researchers.

Availability and readability of patient education materials for deprescribing: An environmental scan – Michael Fajardo et. al.

Thomas Dakin2019-05-16T12:43:52+10:00Deprescribing, Health literacy, Publications|

Over 1/3 of deprescribing patient education materials (PEMs) present potential benefits and harms of deprescribing indicating most of the freely available materials are not balanced. Most PEMs are pitched above average reading levels making them inaccessible for low health literacy populations.

Decision-Making Preferences and Deprescribing: Perspectives of Older Adults and Companions About Their Medicines – Weir et. al.

Josh Beard2023-01-18T14:19:12+11:00Ageing, Deprescribing, Publications, Shared decision making|

New research published in the Journal of Gerontology has found that there are new ways to characterise older people who take multiple medicines and those who are open to “deprescribing”. This is where medicines are reviewed with a view to reducing or stopping less [...]

Deprescribing

Staff Intranet